MICA-129 with methionine binds NKG2D receptor with higher affinity than the variant with valine causing 1) faster and more intensive activation of NK cells associated with a higher risk of acute GvHD, and 2) the coherent early exhaustion of the receptor increasing the risk of relapse [14]. The gene discussed is MICA; the disease is graft versus host disease.